What are the major opportunities in the Psoriasis market? What are the strategies for the Psoriasis market?

For detailed insights on the major opportunities and strategies in the Psoriasis market, Read More

How does the Psoriasis market relate to the overall economy and other similar markets?

For detailed insights on Psoriasis's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Psoriasis market growth? SWOT analysis of the Psoriasis market.

For detailed insights on the key dynamics influencing the Psoriasis market growth and SWOT analysis of the Psoriasis industry, Read More

Psoriasis Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Psoriasis Market Report 2026

Name: Psoriasis Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug class (Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor ), By Drug Types (Small molecules, Biologics ), By Disease Indication (Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis ), By Route Of Administration (Oral, Topical, Injectable ), By Distribution Channel (Hospitals, Retail Pharmacies, E-Commerce) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Psoriasis Market Overview

• Psoriasis market size has reached to $28.93 billion in 2025

• Expected to grow to $44.79 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%

• Growth Driver: Rising Prevalence Of Psoriasis Patients Driving Market Growth Due To Increasing Demand For Advanced Biologic And Targeted Treatment Therapies

• Market Trend: Embedding Autoinjector Delivery Systems For Biosimilar Ustekinumab Therapies

• North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Psoriasis Market?

Psoriasis refers to a skin condition that typically affects the knees, elbows, trunk, and scalp and results with a rash with itchy, scaly spots. The primary contributing factor may be an immune system issue wherein infection-fighting cells unintentionally kill healthy skin cells.

The main classes of drugs in psoriasis are interleukin inhibitors, corticosteroids, anti-inflammatory, and tumor necrosis factor inhibitors. Corticosteroids are a group of steroid hormones generated by vertebrates' adrenal cortex and are also synthetic equivalents of these hormones. The different types of drugs include small molecules and biologics and involve various disease indications such as plaque psoriasis, nail psoriasis, guttate psoriasis, pustular psoriasis, and erythrodermic psoriasis. The several routes of administration include oral, topical, injectable, and distributed through hospitals, retail pharmacies, and e-commerce.

Psoriasis Market Global Report 2026 Market Report bar graph

What Is The Psoriasis Market Size and Share 2026?

The psoriasis market size has grown strongly in recent years. It will grow from $28.93 billion in 2025 to $31.41 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing prevalence of autoimmune skin disorders, widespread corticosteroid usage, improved dermatology diagnosis rates, expansion of hospital dermatology units, growing awareness of chronic skin diseases.

What Is The Psoriasis Market Growth Forecast?

The psoriasis market size is expected to see strong growth in the next few years. It will grow to $44.79 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growth in biologic drug approvals, rising patient awareness, increasing diagnosis of severe psoriasis, expansion of specialty clinics, higher healthcare spending on dermatology. Major trends in the forecast period include rising adoption of biologic therapies for psoriasis, increasing long-term disease management approaches, growing demand for injectable psoriasis treatments, expansion of hospital and specialty dermatology care, increased focus on moderate-to-severe psoriasis.

Book your 30 minutes free consultation with our research experts

Global Psoriasis Market Segmentation

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor

2) By Drug Types: Small molecules, Biologics

3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis

4) By Route Of Administration: Oral, Topical, Injectable

5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce

Subsegments:

1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab)

2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone)

3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade)

What Is The Driver Of The Psoriasis Market?

The rise in the prevalence of psoriasis patients is expected to propel the growth of the psoriasis market going forward. Psoriasis is a chronic autoimmune skin disorder characterized by rapid skin cell buildup leading to inflammation, scaling, and discomfort, often requiring continuous medical treatment and monitoring. The rise in psoriasis patients is due to an overactive immune system mistakenly attacking healthy skin cells, often triggered or exacerbated by environmental factors such as infections, stress, or skin trauma. The growing prevalence of psoriasis supports the psoriasis market by increasing demand for biologics, topical agents, immunomodulators, and phototherapy solutions designed to reduce flare-ups, improve symptoms, and enhance patient quality of life. For instance, in 2025, according to Global Psoriasis Atlas, a UK-based research organization focused on psoriasis, an estimated 43 million people have psoriasis based on physician and dermatologist diagnoses, while approximately 102 million people report having psoriasis based on self-reported cases. Therefore, the rise in the prevalence of psoriasis patients is driving the growth of the psoriasis industry.

Key Players In The Global Psoriasis Market

Major companies operating in the psoriasis market are AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Johnson & Johnson, Amgen Inc., Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy's Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy

Global Psoriasis Market Trends and Insights

Major companies operating in the psoriasis market are focusing on product innovation and formulation such as autoinjector delivery systems for biosimilars, to improve patient adherence, convenience, and treatment outcomes while maintaining the efficacy and safety profiles of reference biologics. These solutions enable self-administration, reduce injection discomfort, and support broader adoption of biosimilar therapies across Europe and other markets. For instance, in May 2025, Sandoz, a Switzerland-based biopharmaceutical company, launched Pyzchiva autoinjector, the first commercially available autoinjector for ustekinumab biosimilars in Europe. The Pyzchiva autoinjector is designed to provide simple, accurate, and patient-friendly administration of biosimilar ustekinumab, supporting improved adherence for chronic psoriasis management. This launch highlights a market trend toward enhancing patient-centric delivery options for biologics and biosimilars, increasing accessibility and convenience for individuals living with psoriasis.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Psoriasis Market?

In October 2024, Organon, a US-based healthcare company, acquired Dermavant Sciences, Inc., for an undisclosed amount. Through this acquisition, Organon aims to enhance its dermatologic therapy portfolio by integrating Dermavant’s innovative treatments, including VTAMA, to address patients with psoriasis and other chronic skin conditions, thereby expanding its presence in the dermatology market. Dermavant Sciences, Inc. is a US-based pharmaceutical company specializing in innovative dermatologic therapies with a strong track record in clinical development for psoriasis and other skin disorders.

Regional Insights

North America was the largest region in the psoriasis market in 2025. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Psoriasis Market?

The psoriasis market consists of sales of Methotrexate, Ciclosporin, and Acitretin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Psoriasis Market Report 2026?

The psoriasis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the psoriasis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Psoriasis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$31.41 billion
Revenue Forecast In 2035	$44.79 billion
Growth Rate	CAGR of 8.5% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug class, Drug Types, Disease Indication, Route Of Administration, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Johnson & Johnson, Amgen Inc., Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Almirall SA, Bausch H
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Psoriasis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Psoriasis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Psoriasis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Psoriasis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Adoption Of Biologic Therapies For Psoriasis

4.2.2 Increasing Long-Term Disease Management Approaches

4.2.3 Growing Demand For Injectable Psoriasis Treatments

4.2.4 Expansion Of Hospital And Specialty Dermatology Care

4.2.5 Increased Focus On Moderate-To-Severe Psoriasis

5. Psoriasis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Dermatology Clinics

5.3 Specialty Skin Care Centers

5.4 Retail Pharmacies

5.5 E-Commerce Pharmacies

6. Psoriasis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Psoriasis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Psoriasis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Psoriasis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Psoriasis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Psoriasis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Psoriasis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Psoriasis Market Segmentation

9.1. Global Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor

9.2. Global Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Small Molecules, Biologics

9.3. Global Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis

9.4. Global Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Tropical, Injectable

9.5. Global Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Retail Pharmacies, E-Commerce

9.6. Global Psoriasis Market, Sub-Segmentation Of Interleukin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab)

9.7. Global Psoriasis Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone)

9.8. Global Psoriasis Market, Sub-Segmentation Of Anti-Inflammatory, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

9.9. Global Psoriasis Market, Sub-Segmentation Of Tumor Necrosis Factor Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade)

10. Psoriasis Market Regional And Country Analysis

10.1. Global Psoriasis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Psoriasis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Psoriasis Market

11.1. Asia-Pacific Psoriasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Psoriasis Market

12.1. China Psoriasis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Psoriasis Market

13.1. India Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Psoriasis Market

14.1. Japan Psoriasis Market Overview

14.2. Japan Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Psoriasis Market

15.1. Australia Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Psoriasis Market

16.1. Indonesia Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Psoriasis Market

17.1. South Korea Psoriasis Market Overview

17.2. South Korea Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Psoriasis Market

18.1. Taiwan Psoriasis Market Overview

18.2. Taiwan Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Psoriasis Market

19.1. South East Asia Psoriasis Market Overview

19.2. South East Asia Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Psoriasis Market

20.1. Western Europe Psoriasis Market Overview

20.2. Western Europe Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Psoriasis Market

21.1. UK Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Psoriasis Market

22.1. Germany Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Psoriasis Market

23.1. France Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Psoriasis Market

24.1. Italy Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Psoriasis Market

25.1. Spain Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Psoriasis Market

26.1. Eastern Europe Psoriasis Market Overview

26.2. Eastern Europe Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Psoriasis Market

27.1. Russia Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Psoriasis Market

28.1. North America Psoriasis Market Overview

28.2. North America Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Psoriasis Market

29.1. USA Psoriasis Market Overview

29.2. USA Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Psoriasis Market

30.1. Canada Psoriasis Market Overview

30.2. Canada Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Psoriasis Market

31.1. South America Psoriasis Market Overview

31.2. South America Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Psoriasis Market

32.1. Brazil Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Psoriasis Market

33.1. Middle East Psoriasis Market Overview

33.2. Middle East Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Psoriasis Market

34.1. Africa Psoriasis Market Overview

34.2. Africa Psoriasis Market, Segmentation By Drug Class, Segmentation By Drug Types, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Psoriasis Market Regulatory and Investment Landscape

36. Psoriasis Market Competitive Landscape And Company Profiles

36.1. Psoriasis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Psoriasis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Psoriasis Market Company Profiles

36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

37. Psoriasis Market Other Major And Innovative Companies

Amgen Inc., Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy's Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co.

38. Global Psoriasis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Psoriasis Market

40. Psoriasis Market High Potential Countries, Segments and Strategies

40.1 Psoriasis Market In 2030 - Countries Offering Most New Opportunities

40.2 Psoriasis Market In 2030 - Segments Offering Most New Opportunities

40.3 Psoriasis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Psoriasis Market, Overview Of Key Products - Product Examples

Table 2: Global Psoriasis Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Psoriasis Market, Supply Chain Analysis

Table 4: Global Psoriasis Market, Major Raw Material Providers

Table 5: Global Psoriasis Market, Major Resource Providers

Table 6: Global Psoriasis Market, Major Manufacturers (Suppliers)

Table 7: Global Psoriasis Market, Major Distributors And Channel Partners

Table 8: Global Psoriasis Market, Key Technologies & Future Trends

Table 9: Global Psoriasis Market, Major Trends

Table 10: Global Psoriasis Market, Major End Users

Table 11: Global Psoriasis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Psoriasis Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Psoriasis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Psoriasis Market - TAM, US$ Billion, 2025

Table 15: Global Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Psoriasis Market, Sub-Segmentation Of Interleukin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Psoriasis Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Psoriasis Market, Sub-Segmentation Of Anti-Inflammatory, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Psoriasis Market, Sub-Segmentation Of Tumor Necrosis Factor Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Psoriasis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Psoriasis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Psoriasis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Psoriasis Market - Company Scoring Matrix

Table 100: AbbVie Inc. Financial Performance

Table 101: Pfizer Inc. Financial Performance

Table 102: Novartis AG Financial Performance

Table 103: Eli Lilly and Company Financial Performance

Table 104: Johnson & Johnson Financial Performance

Table 105: Global Psoriasis Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Psoriasis Market, Competitive Dashboard

Table 107: Global Psoriasis Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Psoriasis Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 109: Global, Psoriasis Market Size Gain ($ Billion), Segmentation By Drug Types, 2025 – 2030

Table 110: Global, Psoriasis Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030

List Of Figures

Figure 1: Global Psoriasis Market, Overview Of Key Products - Product Examples

Figure 2: Global Psoriasis Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Psoriasis Market, Supply Chain Analysis

Figure 4: Global Psoriasis Market, Major Raw Material Providers

Figure 5: Global Psoriasis Market, Major Resource Providers

Figure 6: Global Psoriasis Market, Major Manufacturers (Suppliers)

Figure 7: Global Psoriasis Market, Major Distributors And Channel Partners

Figure 8: Global Psoriasis Market, Key Technologies & Future Trends

Figure 9: Global Psoriasis Market, Major Trends

Figure 10: Global Psoriasis Market, Major End Users

Figure 11: Global Psoriasis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Psoriasis Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Psoriasis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Psoriasis Market - TAM, US$ Billion, 2025

Figure 15: Global Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Psoriasis Market, Sub-Segmentation Of Interleukin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Psoriasis Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Psoriasis Market, Sub-Segmentation Of Anti-Inflammatory, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Psoriasis Market, Sub-Segmentation Of Tumor Necrosis Factor Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Psoriasis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Psoriasis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Psoriasis Market, Segmentation By Drug Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Psoriasis Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Psoriasis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Psoriasis Market - Company Scoring Matrix

Figure 100: AbbVie Inc. Financial Performance

Figure 101: Pfizer Inc. Financial Performance

Figure 102: Novartis AG Financial Performance

Figure 103: Eli Lilly and Company Financial Performance

Figure 104: Johnson & Johnson Financial Performance

Figure 105: Global Psoriasis Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Psoriasis Market, Competitive Dashboard

Figure 107: Global Psoriasis Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Psoriasis Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 109: Global, Psoriasis Market Size Gain ($ Billion), Segmentation By Drug Types, 2025 – 2030

Figure 110: Global, Psoriasis Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Atopic Dermatitis Market Report 2026 - Global Outlook – By Drug Class (Corticosteroids, Emollients Or Moisturizers, IL-4 And PDE4 Inhibitors, Calcineurin Inhibitors, Other Drug Classes), By Mode of Administration (Topica...

Veterinary Dermatology Drugs Market Report 2026 - Global Outlook – By Product Type (Antifungal Drugs, Antibacterial Drugs, Antiparasitic Drugs), By Animal Type (Companion Animal, Livestock Animal), By Drug Indication (Pa...

Scleroderma Market Report 2026 - Global Outlook – By Treatment (Medication, Surgery, Other Treatments), By Indication (Systemic Scleroderma, Localized Scleroderma), By End User (Hospital, Pharmaceutical Stores, Other End...

Seborrheic Dermatitis Market Report 2026 - Global Outlook – By Treatment (Anti-Inflammatory, Antifungal, Corticosteroid, Sulfur Products, Other Treatments), By Dosage Form (Creams, Shampoos, Ointments, Gels, Other Dosage...

Psoriasis Market Report 2026 - Global Outlook – By Drug class (Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor ), By Drug Types (Small molecules, Biologics ), By Disease Indic...

Dermatitis Market Report 2026 - Global Outlook – By Drug Class (Corticosteroids, Emollients Or Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors ), By Distributio...

Dermatology Market Report 2026 - Global Outlook – By Type (Medical Dermatology, Surgical Dermatology, Pediatric Dermatology, Cosmetic Dermatology, Cutaneous Lymphoma, Dermatoimmunology, Other Types ), By Application (Acn...

Frequently Asked Questions

How big is the Psoriasis Market?

The Psoriasis market was valued at $28.93 billion in 2025, increased to $31.41 billion in 2026, and is projected to reach $44.79 billion by 2030. request a sample here

What is the Psoriasis market growth?

The global Psoriasis market is expected to grow at a CAGR of 9.3% from 2026 to 2035 to reach $44.79 billion by 2035. request a sample here

Who are the key players in Psoriasis market?

Some Key Players in the Psoriasis market Include, AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Johnson & Johnson, Amgen Inc., Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy's Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy . request a sample here

What is the anticipated growth trend for the Psoriasis market?

Major trend in this market includes: Embedding Autoinjector Delivery Systems For Biosimilar Ustekinumab Therapies. For further insights on this market. request a sample here

Which region has the most growth potential in the Psoriasis market?

North America was the largest region in the psoriasis market in 2025. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Psoriasis Market Report 2026 market?

Major companies operating in the Psoriasis Market Report 2026 market are Major companies operating in the psoriasis market are AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Johnson & Johnson, Amgen Inc., Merck & Co. Inc., Janssen Biotec request a sample here.